Your browser is no longer supported. Please, upgrade your browser.
Settings
LOGC [NASD]
LogicBio Therapeutics, Inc.
Index- P/E- EPS (ttm)-1.21 Insider Own13.49% Shs Outstand32.16M Perf Week-6.14%
Market Cap122.35M Forward P/E- EPS next Y-1.42 Insider Trans-0.03% Shs Float26.94M Perf Month-20.25%
Income-35.70M PEG- EPS next Q-0.30 Inst Own59.60% Short Float2.18% Perf Quarter-9.69%
Sales2.70M P/S45.32 EPS this Y27.60% Inst Trans0.10% Short Ratio6.97 Perf Half Y-36.44%
Book/sh1.39 P/B2.75 EPS next Y-12.70% ROA-52.10% Target Price18.80 Perf Year-33.45%
Cash/sh- P/C- EPS next 5Y- ROE-78.20% 52W Range3.72 - 9.74 Perf YTD-49.93%
Dividend- P/FCF- EPS past 5Y- ROI-44.40% 52W High-60.80% Beta-
Dividend %- Quick Ratio4.90 Sales past 5Y- Gross Margin- 52W Low2.68% ATR0.26
Employees39 Current Ratio4.90 Sales Q/Q-20.00% Oper. Margin- RSI (14)36.89 Volatility5.65% 6.43%
OptionableYes Debt/Eq0.22 EPS Q/Q7.40% Profit Margin- Rel Volume0.53 Prev Close3.82
ShortableYes LT Debt/Eq0.15 EarningsAug 09 BMO Payout- Avg Volume84.45K Price3.82
Recom1.70 SMA20-8.69% SMA50-13.06% SMA200-32.55% Volume45,588 Change0.00%
Jun-07-21Initiated H.C. Wainwright Buy $15
Mar-04-21Initiated JMP Securities Mkt Outperform $17
May-01-19Initiated ROTH Capital Buy $26
Oct-21-21 08:00AM  
Oct-18-21 08:00AM  
Oct-12-21 04:05PM  
Sep-24-21 04:05PM  
Sep-14-21 09:33AM  
Sep-10-21 08:00AM  
Aug-09-21 09:15AM  
08:00AM  
Jul-16-21 04:52AM  
Jul-08-21 07:00AM  
Jun-28-21 01:11PM  
Jun-02-21 07:00AM  
Jun-01-21 04:05PM  
May-19-21 07:00AM  
May-17-21 07:08AM  
May-10-21 07:30AM  
07:05AM  
May-04-21 08:00AM  
May-03-21 04:30PM  
Apr-27-21 09:51AM  
07:00AM  
07:00AM  
07:00AM  
Mar-30-21 04:30PM  
Mar-17-21 04:26AM  
Mar-15-21 05:32PM  
Feb-26-21 02:15PM  
Jan-07-21 08:00AM  
Jan-06-21 08:00AM  
Dec-22-20 08:00AM  
Dec-18-20 02:43AM  
Dec-14-20 08:00AM  
Dec-04-20 11:13AM  
Dec-03-20 08:52AM  
Nov-29-20 09:45AM  
Nov-12-20 04:05PM  
Nov-09-20 06:30AM  
Nov-04-20 07:45AM  
Nov-03-20 04:05PM  
Oct-31-20 08:00AM  
Oct-05-20 11:12AM  
Oct-01-20 09:10AM  
Sep-30-20 04:01PM  
Sep-29-20 11:21AM  
Sep-25-20 07:49PM  
07:47PM  
Sep-14-20 12:59PM  
Aug-10-20 06:35AM  
06:30AM  
Jul-20-20 10:58AM  
Jun-05-20 07:00AM  
Jun-03-20 09:24PM  
May-28-20 07:00AM  
May-18-20 12:15PM  
11:56AM  
10:28AM  
May-17-20 07:45PM  
04:46PM  
02:23PM  
01:00PM  
May-16-20 03:05PM  
09:47AM  
May-15-20 01:25PM  
01:15PM  
12:54PM  
09:56AM  
09:46AM  
May-14-20 03:50PM  
01:00PM  
09:37AM  
May-13-20 08:40PM  
12:56PM  
09:51AM  
May-12-20 10:25PM  
02:15PM  
09:37AM  
08:17AM  
May-11-20 08:10PM  
04:10PM  
04:05PM  
12:53PM  
May-10-20 01:30PM  
12:20PM  
May-08-20 06:15PM  
May-07-20 03:15PM  
10:28AM  
May-06-20 04:50PM  
01:01PM  
May-05-20 07:45PM  
04:15PM  
May-04-20 01:55PM  
May-03-20 09:30AM  
May-01-20 06:15PM  
12:47PM  
Apr-30-20 05:37PM  
Apr-29-20 09:30PM  
08:05PM  
05:00PM  
Apr-28-20 11:00AM  
Apr-27-20 02:37PM  
LogicBio Therapeutics, Inc., a genome editing company, focuses on developing medicines to treat rare diseases in patients with unmet medical need using GeneRide technology platform. The GeneRide technology is designed to integrate corrective genes into a patient's genome to provide a therapeutic effect. The company's lead product candidate is LB-001 that is in Phase I/II clinical trials for the treatment of methylmalonic acidemia. It has a collaboration with Children's Medical Research Institute to develop next-generation capsids for gene therapy and gene editing applications in the liver, as well as two additional tissues; and a collaboration agreement with Takeda Pharmaceutical Company Limited to develop next-generation capsids for gene therapy and editing candidate LB-301 for the treatment of crigler-najjar syndrome. The company also has a strategic collaboration and option agreement with CANbridge Pharmaceuticals Inc. The company was incorporated in 2014 and is headquartered in Lexington, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gruskin DanielChief Medical OfficerAug 09Sale4.351,4676,3813,331Aug 10 06:31 PM
Chereau FredericPresident and Chief ExecutiveApr 16Sale5.737,54243,216253,811Apr 19 09:00 PM
Chiang KyleChief Operating OfficerApr 16Sale5.732,97717,05823,387Apr 19 09:00 PM